FOLH1 and prostate carcinoma: In the case of prostate cancer, growth-inhibitory antibodies, metastasis-inhibitory antibodies, and angiogenesis-inhibitory antibodies can be mentioned (109)Among the antigens for which antibodies have been produced to treat PC is PSMA.